Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic immune demyelinating neuropathies

G Lopate1, A Pestronk

  • 1Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110.

Seminars in Neurology
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement.

Journal of neurology, neurosurgery, and psychiatry·2015
Same author

Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy.

Neurology·2012
Same author

Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design.

Neurology·2011
Same author

Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy.

Neurology·2011
Same author

Dominant spinal muscular atrophy with lower extremity predominance: linkage to 14q32.

Neurology·2010
Same author

[A transferable "Myasthenogenic" factor in the serum of patients with myasthenia gravis.].

Journal of neurology·2010
Same journal

Isolated Cranial Tremors: A Reappraisal.

Seminars in neurology·2026
Same journal

Dystonia and Tremor.

Seminars in neurology·2026
Same journal

Pendular nystagmus and oculopalatal tremor.

Seminars in neurology·2026
Same journal

Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD.

Seminars in neurology·2026
Same journal

Tremor.

Seminars in neurology·2026
Same journal

Carotid Disease.

Seminars in neurology·2026
See all related articles

Recent advancements have refined the classification of immune-mediated demyelinating polyneuropathies, moving beyond broad chronic inflammatory demyelinating polyneuropathy (CIDP) definitions. Subdividing these conditions is crucial due to distinct clinical features, antibody patterns, and treatment responses.

Area of Science:

  • Neurology
  • Immunology
  • Clinical Medicine

Background:

  • The classification of immune-mediated demyelinating polyneuropathies has evolved, with initial definitions of chronic inflammatory demyelinating polyneuropathy (CIDP) being broad.
  • This broadness encompassed various acquired polyneuropathies exhibiting demyelinating features.

Purpose of the Study:

  • To justify the subdivision of acquired demyelinating polyneuropathies into distinct categories.
  • To highlight the clinical and immunological distinctions among these conditions.

Main Methods:

  • Review and synthesis of existing literature on immune-mediated demyelinating polyneuropathies.
  • Analysis of clinical syndromes, serum antibody binding patterns, and treatment responses.

Main Results:

Related Experiment Videos

  • Identification of several distinct clinical syndromes within acquired demyelinating polyneuropathies.
  • Association of specific serum antibody binding patterns with each distinct clinical syndrome.
  • Differential responses of these syndromes to immune-modulating treatments.

Conclusions:

  • Subdivision of acquired demyelinating polyneuropathies is clinically and immunologically justified.
  • Further large-scale studies and controlled trials are needed to optimize treatment strategies for these distinct syndromes.